Gabor Domokos

1.2k total citations
33 papers, 951 citations indexed

About

Gabor Domokos is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gabor Domokos has authored 33 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 25 papers in Hematology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gabor Domokos's work include Hemoglobinopathies and Related Disorders (29 papers), Iron Metabolism and Disorders (16 papers) and Acute Myeloid Leukemia Research (8 papers). Gabor Domokos is often cited by papers focused on Hemoglobinopathies and Related Disorders (29 papers), Iron Metabolism and Disorders (16 papers) and Acute Myeloid Leukemia Research (8 papers). Gabor Domokos collaborates with scholars based in Switzerland, United States and Italy. Gabor Domokos's co-authors include Bernard Roubert, Dany Habr, John B. Porter, Maria Domenica Cappellini, Alì Taher, Vip Viprakasit, Amal El‐Beshlawy, Chi Kong Li, Antonis Kattamis and Mohsen Saleh Elalfy and has published in prestigious journals such as Blood, Haematologica and European Journal Of Haematology.

In The Last Decade

Gabor Domokos

33 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabor Domokos Switzerland 11 854 849 158 106 31 33 951
Bernard Roubert Switzerland 11 933 1.1× 914 1.1× 164 1.0× 104 1.0× 36 1.2× 24 1.0k
Paolo Rigano Italy 17 367 0.4× 450 0.5× 121 0.8× 19 0.2× 52 1.7× 33 524
Maria Rosaria Fasulo Italy 9 429 0.5× 387 0.5× 50 0.3× 22 0.2× 46 1.5× 16 545
F Argiolu Italy 12 420 0.5× 380 0.4× 177 1.1× 26 0.2× 59 1.9× 19 633
Lee Lee Chan Malaysia 9 256 0.3× 243 0.3× 79 0.5× 40 0.4× 7 0.2× 22 340
Eunice Sindhuvi Edison India 12 257 0.3× 211 0.2× 71 0.4× 39 0.4× 40 1.3× 51 390
Haraprasad Pati India 11 233 0.3× 172 0.2× 57 0.4× 9 0.1× 54 1.7× 46 335
Jessica L Sea United States 4 161 0.2× 72 0.1× 53 0.3× 124 1.2× 32 1.0× 10 442
Omar Niss United States 13 417 0.5× 490 0.6× 102 0.6× 4 0.0× 118 3.8× 39 633
Áurea Cervera Spain 11 152 0.2× 130 0.2× 49 0.3× 42 0.4× 43 1.4× 40 379

Countries citing papers authored by Gabor Domokos

Since Specialization
Citations

This map shows the geographic impact of Gabor Domokos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabor Domokos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabor Domokos more than expected).

Fields of papers citing papers by Gabor Domokos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabor Domokos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabor Domokos. The network helps show where Gabor Domokos may publish in the future.

Co-authorship network of co-authors of Gabor Domokos

This figure shows the co-authorship network connecting the top 25 collaborators of Gabor Domokos. A scholar is included among the top collaborators of Gabor Domokos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabor Domokos. Gabor Domokos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2012). Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with  -thalassemia major. Haematologica. 97(6). 842–848. 107 indexed citations
2.
Porter, John B., Kai‐Hsin Lin, Photis Beris, et al.. (2011). Response of iron overload to deferasirox in rare transfusion‐dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias. European Journal Of Haematology. 87(4). 338–348. 24 indexed citations
3.
Viprakasit, Vip, Hishamshah Mohd Ibrahim, Sy Ha, et al.. (2011). Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: a subanalysis of the EPIC study of deferasirox. International Journal of Hematology. 93(3). 319–328. 10 indexed citations
4.
Gattermann, Norbert, Carlo Finelli, Matteo Giovanni Della Porta, et al.. (2010). Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study. Leukemia Research. 34(9). 1143–1150. 138 indexed citations
5.
Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2010). Continued improvement in myocardial T2* over two years of deferasirox therapy in  -thalassemia major patients with cardiac iron overload. Haematologica. 96(1). 48–54. 61 indexed citations
6.
Lee, Jong Wook, Sung‐Soo Yoon, Arnold Ganser, et al.. (2010). Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. Blood. 116(14). 2448–2454. 56 indexed citations
7.
Cappellini, Maria Domenica, John B. Porter, Amal El‐Beshlawy, et al.. (2009). Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Haematologica. 95(4). 557–566. 233 indexed citations
8.
Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2009). Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia. Blood. 115(12). 2364–2371. 158 indexed citations
9.
10.
Gattermann, Norbert, Mathias Schmid, Agnès Guerci‐Bresler, et al.. (2009). Correlation Between Decreased Serum Ferritin and Improved Liver Transaminases During Deferasirox (Exjade®) Treatment in Iron-Overloaded Patients with Myelodysplastic Syndromes.. Blood. 114(22). 3803–3803. 4 indexed citations
11.
Pennell, Dudley J., John B. Porter, Cappellini, et al.. (2009). EFFICACY AND SAFETY OF DEFERASIROX IN REDUCING MYOCARDIAL SIDEROSIS IN PATIENTS WITH B-THALASSAEMIA MAJOR. UCL Discovery (University College London). 94. 74–75. 1 indexed citations
12.
Lee, Jong Wook, Sung‐Soo Yoon, Hui‐Chi Hsu, et al.. (2008). Iron Chelation in Regularly Transfused Patients with Aplastic Anemia: Efficacy and Safety Results from the Large Deferasirox EPIC Trial. Blood. 112(11). 439–439. 3 indexed citations
13.
Cappellini, Maria Domenica, Mohsen Saleh Elalfy, Antonis Kattamis, et al.. (2008). Efficacy and Safety of Once-Daily, Oral Iron Chelator Deferasirox (Exjade®) in a Large Group of Regularly Transfused Patients with β-Thalassemia Major. Blood. 112(11). 3878–3878. 4 indexed citations
14.
15.
Gattermann, Norbert, Mathias Schmid, Matteo Giovanni Della Porta, et al.. (2008). Efficacy and Safety of Deferasirox (Exjade®) during 1 Year of Treatment in Transfusion-Dependent Patients with Myelodysplastic Syndromes: Results from EPIC Trial. Blood. 112(11). 633–633. 17 indexed citations
16.
Pennell, Dudley J., John B. Porter, Maria Domenica Cappellini, et al.. (2008). Efficacy and Safety of Deferasirox (Exjade®) in Reducing Cardiac Iron in Patients with β-Thalassemia Major: Results from the Cardiac Substudy of the EPIC Trial. Blood. 112(11). 3873–3873. 19 indexed citations
17.
Porter, John B., Donald K. Bowden, Arnold Ganser, et al.. (2008). Improved Health-Related Quality of Life in Patients with Hematological Disorders Receiving Deferasirox (Exjade®). Blood. 112(11). 1307–1307. 10 indexed citations
18.
Domokos, Gabor, et al.. (1992). Preparation, properties and biological function of liposome encapsulated hemoglobin. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 345–354. 4 indexed citations
19.
Clauss, Wolfgang, Gabor Domokos, & Elke Leng-Peschlow. (1988). Effect of Rhein on Electrogenic Chloride Secretion in Rabbit Distal Colon. Pharmacology. 36(1). 104–110. 6 indexed citations
20.
Domokos, Gabor, et al.. (1982). Direct effect of diagnostic ultrasound on genetically interesting molecules: a theoretical model.. PubMed. 5. 199–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernard Roubert Breakdown of academic impact, for papers by Paolo Rigano Breakdown of academic impact, for papers by Maria Rosaria Fasulo Breakdown of academic impact, for papers by F Argiolu Breakdown of academic impact, for papers by Lee Lee Chan Breakdown of academic impact, for papers by Eunice Sindhuvi Edison Breakdown of academic impact, for papers by Haraprasad Pati Breakdown of academic impact, for papers by Jessica L Sea Breakdown of academic impact, for papers by Omar Niss Breakdown of academic impact, for papers by Áurea Cervera
Rankless by CCL
2026